Liaoning issued a document: 169 drugs were "stopped" procurement without review

Recently, Liaoning Province’s Drug and Medical Consumables Centralized Procurement Network issued an announcement stating that more than 3 drugs (in terms of specifications) of the same type of drugs (in terms of specifications) purchased online in Liaoning Province have been reviewed (generic drugs approved under the new registration classification are deemed to have been approved) The evaluation is included in the scope of statistics, and the reference preparations and original research drugs are not included in the scope of statistics), the online procurement of other unreviewed drugs that have been purchased online in Liaoning Province is suspended, and the unreviewed drugs that have not been online in Liaoning Province are temporarily not included.
Included in the scope of centralized procurement in Liaoning Province
.
According to the announcement, as of October 20, 2021, Liaoning Province intends to suspend online purchases of 169 drugs that have not been reviewed, involving 111 companies including Chenxin Pharmaceutical, North China Pharmaceutical, Shijiazhuang Siyao, Qilu Pharmaceutical, etc.
Injections accounted for the majority, with a total of 159, including iohexol injection, metronidazole sodium chloride injection, rocuronium injection, milrinone injection, cefixime dispersible tablets, ropivacaine hydrochloride injection Solution, Palonosetron Hydrochloride Injection, Azithromycin for Injection, Esomeprazole Sodium for Injection, Decitabine for Injection, Lansoprazole for Injection, Meropenem for Injection, Pantoprazole Sodium for Injection , Pemetrexed disodium for injection, tigecycline for injection, ceftriaxone sodium for injection, thymus facine for injection, levofloxacin hydrochloride sodium chloride injection, levofloxacin lactate sodium chloride injection, gemcitabine hydrochloride for injection and so on
.
The author noticed that among the drugs that have been “halted” procurement, there are many large varieties of injections.
For example, the contrast agent product “Iohexol injection” is still performing well after the terminal sales of Chinese public medical institutions exceeded 3.
5 billion yuan in 2017.
The growth rate of the company continued to grow, reaching 3.
837 billion yuan in 2019, a year-on-year increase of 3.
52%
.
According to the research of relevant securities companies, the national sales of iohexol injection will be about 4 billion yuan in 2020; another example is the new generation of proton pump inhibitor (PPI) esomeprazole sodium.
The sales of sodium azole in urban public and county-level public hospitals in 2019 were 3.
3 billion yuan, and sales in the first half of 2020 exceeded 1.
5 billion yuan
.
On March 5, 2016, the "Opinions on Carrying out the Evaluation of the Quality and Efficacy Consistency of Generic Drugs" issued by my country clearly requires that more than 3 manufacturers of the same type of drugs have passed the consistency evaluation.
In terms of centralized drug procurement, etc.
No longer select varieties that have not passed the consistency evaluation
.
Since then, many provinces and cities across the country have successively implemented the regulations of "the suspension of trading qualifications for three unqualified manufacturers that have passed the consistency evaluation"
.
It is reported that Liaoning Province actively responded to the policy.
For example, as early as October 14, 2019, Liaoning Province issued two notifications for drugs and medical consumables to further standardize the online procurement of drugs through consistency evaluation
.
This time Liaoning Province announced a list of 177 suspended online drugs, including amoxicillin capsules, amlodipine besylate tablets, entecavir dispersible tablets, entecavir capsules, glimepiride tablets, polyethylene glycol 4000 powder, Peridone tablets, montmorillonite powder, rosuvastatin calcium tablets, cefuroxime axetil tablets, metformin hydrochloride sustained-release tablets, metformin hydrochloride tablets, levocetirizine hydrochloride tablets, involving 105 companies; May 28, 2020 On the same day, Liaoning Province’s centralized procurement network for pharmaceuticals and medical consumables issued the "Notice on Suspension of Online Procurement of Certain Drugs", in which 64 unreviewed drugs were suspended from procurement
.
With the advancement of the consistency rating policy, the industry believes that the consistency evaluation of generic drugs has accelerated into the "knockout" link
.
In the future, products that fail to pass the consistency evaluation will gradually be eliminated, and the market share of high-quality generic drugs will continue to increase
.